These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7845532)

  • 1. Transferrin receptors in the parkinsonian midbrain.
    Morris CM; Candy JM; Omar S; Bloxham CA; Edwardson JA
    Neuropathol Appl Neurobiol; 1994 Oct; 20(5):468-72. PubMed ID: 7845532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease.
    Faucheux BA; Hirsch EC; Villares J; Selimi F; Mouatt-Prigent A; Javoy-Agid F; Hauw JJ; Agid Y
    J Neurochem; 1993 Jun; 60(6):2338-41. PubMed ID: 8492137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.
    Faucheux BA; Hauw JJ; Agid Y; Hirsch EC
    Brain Res; 1997 Feb; 749(1):170-4. PubMed ID: 9070646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
    Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats.
    He Y; Lee T; Leong SK
    Neuroscience; 1999; 91(2):579-85. PubMed ID: 10366015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin receptors in the normal human hippocampus and in Alzheimer's disease.
    Morris CM; Candy JM; Kerwin JM; Edwardson JA
    Neuropathol Appl Neurobiol; 1994 Oct; 20(5):473-7. PubMed ID: 7845533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of excitatory amino acid receptors in the normal human midbrain and basal ganglia with implications for Parkinson's disease: a quantitative autoradiographic study using [3H]MK-801, [3H]glycine, [3H]CNQX and [3H]kainate.
    Ball EF; Shaw PJ; Ince PG; Johnson M
    Brain Res; 1994 Sep; 658(1-2):209-18. PubMed ID: 7834343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
    Thibaut F; Hirsch EC; Raisman R; Javoy-Agid F; Agid Y
    Neuroscience; 1990; 37(2):387-98. PubMed ID: 1983469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.
    Mash DC; Pablo J; Buck BE; Sanchez-Ramos J; Weiner WJ
    Exp Neurol; 1991 Oct; 114(1):73-81. PubMed ID: 1915737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.
    Mastroberardino PG; Hoffman EK; Horowitz MP; Betarbet R; Taylor G; Cheng D; Na HM; Gutekunst CA; Gearing M; Trojanowski JQ; Anderson M; Chu CT; Peng J; Greenamyre JT
    Neurobiol Dis; 2009 Jun; 34(3):417-31. PubMed ID: 19250966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered systemic iron metabolism in Parkinson's disease.
    Logroscino G; Marder K; Graziano J; Freyer G; Slavkovich V; LoIacono N; Cote L; Mayeux R
    Neurology; 1997 Sep; 49(3):714-7. PubMed ID: 9305329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease: depletion of substantia nigra neurotensin receptors.
    Uhl GR; Whitehouse PJ; Price DL; Tourtelotte WW; Kuhar MJ
    Brain Res; 1984 Aug; 308(1):186-90. PubMed ID: 6089953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
    Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
    Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys.
    Faucheux BA; Herrero MT; Villares J; Levy R; Javoy-Agid F; Obeso JA; Hauw JJ; Agid Y; Hirsch EC
    Brain Res; 1995 Sep; 691(1-2):115-24. PubMed ID: 8590043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
    Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
    Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
    Kastner A; Hirsch EC; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
    J Neurochem; 1992 Sep; 59(3):1080-9. PubMed ID: 1494900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
    Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.
    Dexter DT; Wells FR; Lees AJ; Agid F; Agid Y; Jenner P; Marsden CD
    J Neurochem; 1989 Jun; 52(6):1830-6. PubMed ID: 2723638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?
    Mouatt-Prigent A; Karlsson JO; Agid Y; Hirsch EC
    Neuroscience; 1996 Aug; 73(4):979-87. PubMed ID: 8809817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.